Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 7340
Country/Region: Uganda
Year: 2008
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Own Agency
Funding Agency: HHS/CDC
Total Funding: $190,000

Funding for Strategic Information (HVSI): $190,000

In FY08 CDC will continue to work with Health Strategies International, a U.S. health economics consulting

firm, to finalize the cost-effectiveness evaluation of antiretroviral therapy (ART) using a home-based model

for ART delivery (HBAC) in Tororo. The project which has evaluated the impact of ART on household

economics in rural Uganda is based on HBAC I data as well as previous evaluation data from CDC-Uganda

for cotrimoxazole and the safe water vessel. As applicable,the impact on family members was also be

assessed. A sub-component of the evaluation is to conduct time and motion studies of various service

providers within ART programs, including field officers, counselors, laboratory technicians and medical

officers. Final results will be shared initially with the primary partners in the project, MOH and The AIDS

Support Organisation (TASO), and then will be disseminated broadly. Project implementation also includes

training in data collection, data analysis and the preparation of presentations and manuscripts for